Our results suggest that the anti-β2GP1 antibodies of the IgA isotype found in patients with clinical signs of thrombosis recognize zones of the molecule previously identified by the aPL monoclonals from patients with APS that are capable of inducing APS in animal models. Here, FASLG is linked to deep vein thrombosis.